Clinical Trials
Pharmaxis has conducted a number of clinical trials as part of the regulatory approvals process for Bronchitol.
Skip to
Cystic Fibrosis
Phase
IV
| Description | Five Year Post Authorisation Safety Study of Bronchitol (Inhaled Mannitol) in the UK |
|---|---|
| Sites | UK Patient Registry |
| Subjects | 1,349 |
| Status | Complete |
| More Information | |
| Media Releases |
Phase
III
| Description | CF303: Treatment of adults with Cystic Fibrosis |
|---|---|
| Sites | 126 Sites in Europe , Australia, Middle East, New Zealand, North America, Russia, South Africa, South America |
| Subjects | 423 |
| Status | Complete |
| More Information | |
| Media Releases |
Phase
III
* ClinicalTrials.gov is a service provided by the U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine. ClinicalTrials.gov provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions. Pharmaxis chooses to publish all Pivotal Trials on the ClinicalTrials.gov website.
** Pubmed is a service of the U.S. National Library of Medicine and the National Institutes of Health.
*** No further clinical development planned in Bronchiectasis